Literature DB >> 16094056

Quality of care: partial cystectomy for bladder cancer--a case of inappropriate use?

Brent K Hollenbeck1, David A Taub, Rodney L Dunn, John T Wei.   

Abstract

PURPOSE: Partial cystectomy is perceived to be a less morbid, less technically demanding procedure than radical cystectomy, although only select patients (approximately 6% to 10%) are appropriate candidates (solitary tumor in space/time, absence of carcinoma in situ). From a quality of care perspective, overuse of partial cystectomy may signify inappropriate delivery of health care.
MATERIALS AND METHODS: Subjects who underwent extirpative treatment for bladder cancer between 1988 and 2000 were identified within the Surveillance, Epidemiology and End Results (SEER, 3,381) registry and the Nationwide Inpatient Sample (NIS, 22,088). Adjusted models were developed to identify clinical factors independently associated with the use of partial cystectomy for bladder cancer treatment within each sample.
RESULTS: Among patients who underwent extirpative surgery for bladder cancer, 18% and 20% of those in SEER and NIS, respectively, underwent partial cystectomy. Significant decreases in use between early and later years were noted in both samples (SEER-22% to 13%, NIS-24% to 17%, both p <0.0001). Partial cystectomy was preferentially used in the elderly, those with stage I disease, females and black patients. Furthermore, partial cystectomy was more commonly provided in rural, nonteaching, low volume hospitals.
CONCLUSIONS: Trends in national use of partial cystectomy are consistent between the NIS and SEER with 13% to 17% of patients currently being treated with partial in lieu of radical cystectomy. Partial cystectomy is disproportionately used in certain medical centers (nonteaching, rural, low volume) and patient populations (elderly, black, females, stage I disease) reflecting selective referral or overuse.

Entities:  

Mesh:

Year:  2005        PMID: 16094056     DOI: 10.1097/01.ju.0000169477.30477.3d

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  11 in total

1.  Sources of variation in follow-up expenditure after radical cystectomy.

Authors:  Goutham Vemana; Joel Vetter; Ling Chen; Gurdarshan Sandhu; Seth A Strope
Journal:  Urol Oncol       Date:  2015-04-20       Impact factor: 3.498

2.  Impact of Surgical Technique on Surgical Margin Status Following Partial Cystectomy.

Authors:  Michael Owyong; Tulay Koru-Sengul; Feng Miao; Shirin Razdan; Kevin J Moore; Mahmoud Alameddine; Sanoj Punnen; Dipen J Parekh; Chad R Ritch; Mark L Gonzalgo
Journal:  Urol Oncol       Date:  2019-08-21       Impact factor: 3.498

3.  Racial variation in the quality of surgical care for bladder cancer.

Authors:  Daniel A Barocas; Joann Alvarez; Tatsuki Koyama; Christopher B Anderson; Darryl T Gray; Jay H Fowke; Chaochen You; Sam S Chang; Michael S Cookson; Joseph A Smith; David F Penson
Journal:  Cancer       Date:  2013-12-11       Impact factor: 6.860

4.  Partial cystectomy for urothelial carcinoma of the bladder: Practice patterns and outcomes in the general population.

Authors:  Michael J Leveridge; D Robert Siemens; Jason P Izard; Xuejiao Wei; Christopher M Booth
Journal:  Can Urol Assoc J       Date:  2017-11-01       Impact factor: 1.862

5.  Performance of partial cystectomy in the United States from 2001 to 2010: trends and comparative outcomes.

Authors:  Izak Faiena; Viktor Dombrovskiy; Christopher Koprowski; Eric A Singer; Thomas L Jang; Robert E Weiss
Journal:  Can J Urol       Date:  2014-12       Impact factor: 1.344

6.  Proximal and distal colorectal cancer resection rates in the United States since widespread screening by colonoscopy.

Authors:  Parvathi A Myer; Ajitha Mannalithara; Gurkirpal Singh; Uri Ladabaum
Journal:  Gastroenterology       Date:  2012-07-27       Impact factor: 22.682

7.  Practice patterns and recurrence after partial cystectomy for bladder cancer.

Authors:  Nader Fahmy; Armen Aprikian; Simon Tanguay; Salaheddin M Mahmud; Mohammed Al-Otaibi; Suganthiny Jeyaganth; Moamen Amin; Wassim Kassouf
Journal:  World J Urol       Date:  2009-10-14       Impact factor: 4.226

Review 8.  SIU-ICUD consultation on bladder cancer: treatment of muscle-invasive bladder cancer.

Authors:  Jeffrey J Leow; Jens Bedke; Karim Chamie; Justin W Collins; Siamak Daneshmand; Petros Grivas; Axel Heidenreich; Edward M Messing; Trevor J Royce; Alexander I Sankin; Mark P Schoenberg; William U Shipley; Arnauld Villers; Jason A Efstathiou; Joaquim Bellmunt; Arnulf Stenzl
Journal:  World J Urol       Date:  2019-01-25       Impact factor: 4.226

9.  Cystoscopic-assisted partial cystectomy: description of technique and results.

Authors:  Ofer N Gofrit; Amos Shapiro; Ran Katz; Mordechai Duvdevani; Vladimir Yutkin; Ezekiel H Landau; Kevin C Zorn; Guy Hidas; Dov Pode
Journal:  Res Rep Urol       Date:  2014-10-24

10.  Oncological outcomes, quality of life outcomes and complications of partial cystectomy for selected cases of muscle-invasive bladder cancer.

Authors:  Jan Ebbing; Robin Colja Heckmann; Justin William Collins; Kurt Miller; Barbara Erber; Frank Friedersdorff; Tom Florian Fuller; Jonas Busch; Hans Helge Seifert; Peter Ardelt; Christian Wetterauer; Abolfazl Hosseini; Florian Jentzmik; Carsten Kempkensteffen
Journal:  Sci Rep       Date:  2018-05-30       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.